BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities
July 10, 2026
Cannabics Pharmaceuticals’ Drug Candidate Exhibits 30% Tumor Volume Reduction in Mice
June 28, 2021
Related Post
-
-
IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx(TM) DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
July 9, 2026
-
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics
July 9, 2026
-
BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities
July 8, 2026